- cafead   Sep 18, 2024 at 12:02: PM
via The US Food and Drug Administration (FDA) has lifted a partial clinical hold on Zentalis Pharmaceuticals’ azenosertib, allowing the company to continue evaluating the drug as a treatment for cancer.
article source
article source